10-Q Filing

ELANCO ANIMAL HEALTH INC CIK: 1739104 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001739104-19-000012`
Period End Date	20190630
Filing Date	20190813
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	elan-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 66 Cash Flow Statement 52 Stockholders Equity 31 Comprehensive Income 24

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$8.40M	USD	Point-in-time
Accounts receivable, allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$5.70M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$878.60M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$921.20M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$321.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	5.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	5.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$385.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$474.80M	USD	Point-in-time
Accounts receivable, net of allowances of $5.7 (2019) and $8.4 (2018)	`AccountsReceivableNetCurrent`	$651.80M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	365.64M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	365.71M	shares	Point-in-time
Accounts receivable, net of allowances of $5.7 (2019) and $8.4 (2018)	`AccountsReceivableNetCurrent`	$757.20M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$57.60M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	365.71M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	365.64M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$74.30M	USD	Point-in-time
Inventories (Note 7)	`InventoryNet`	$1.00B	USD	Point-in-time
Inventories (Note 7)	`InventoryNet`	$1.05B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$102.30M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$113.90M	USD	Point-in-time
Restricted cash (Note 15)	`RestrictedCashCurrent`	$202.70M	USD	Point-in-time
Restricted cash (Note 15)	`RestrictedCashCurrent`	$11.50M	USD	Point-in-time
Restricted cash (Note 15)	`RestrictedCashCurrent`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.50B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.38B	USD	Point-in-time
Goodwill	`Goodwill`	$2.96B	USD	Point-in-time
Goodwill	`Goodwill`	$2.96B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$2.45B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$2.35B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$229.90M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$118.40M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $921.2 (2019) and $878.6 (2018)	`PropertyPlantAndEquipmentNet`	$931.10M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $921.2 (2019) and $878.6 (2018)	`PropertyPlantAndEquipmentNet`	$922.40M	USD	Point-in-time
Total assets	`Assets`	$8.96B	USD	Point-in-time
Total assets	`Assets`	$8.86B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$242.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$205.20M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$67.30M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$98.90M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$176.00M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$169.90M	USD	Point-in-time
Current portion of long-term debt (Note 8)	`LongTermDebtCurrent`	$29.00M	USD	Point-in-time
Current portion of long-term debt (Note 8)	`LongTermDebtCurrent`	$27.10M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$199.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$205.40M	USD	Point-in-time
Payable to Lilly (Note 15)	`DueToRelatedPartiesNoncurrent`	$58.80M	USD	Point-in-time
Payable to Lilly (Note 15)	`DueToRelatedPartiesNoncurrent`	$268.70M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$777.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$970.70M	USD	Point-in-time
Long-term debt (Note 8)	`LongTermDebtNoncurrent`	$2.44B	USD	Point-in-time
Long-term debt (Note 8)	`LongTermDebtNoncurrent`	$2.38B	USD	Point-in-time
Accrued retirement benefits	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$108.40M	USD	Point-in-time
Accrued retirement benefits	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$109.10M	USD	Point-in-time
Deferred taxes (Note 11)	`DeferredIncomeTaxLiabilitiesNet`	$147.80M	USD	Point-in-time
Deferred taxes (Note 11)	`DeferredIncomeTaxLiabilitiesNet`	$114.60M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$121.50M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$175.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.59B	USD	Point-in-time
Total liabilities	`Liabilities`	$3.76B	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, no par value, 5,000,000,000 shares authorized, 365,707,233 and 365,643,911 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, no par value, 5,000,000,000 shares authorized, 365,707,233 and 365,643,911 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.40B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.40B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$16.40M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$83.80M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-214.80M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-222.20M	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.20B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.27B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.78B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.58B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.90B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.20B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.96B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.86B	USD	Point-in-time

Income Statement 66 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.51B	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$770.20M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.51B	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$781.60M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$791.50M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$356.00M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$699.80M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$431.50M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$132.90M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$126.60M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$68.80M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$61.40M	USD	1 Quarter
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$382.00M	USD	2 Qtrs
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$191.10M	USD	1 Quarter
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$200.90M	USD	1 Quarter
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$371.10M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$49.40M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$49.30M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$98.30M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$98.60M	USD	2 Qtrs
Asset impairment, restructuring and other special charges (Note 6)	`RestructuringSettlementAndImpairmentProvisions`	$68.00M	USD	1 Quarter
Asset impairment, restructuring and other special charges (Note 6)	`RestructuringSettlementAndImpairmentProvisions`	$70.40M	USD	2 Qtrs
Asset impairment, restructuring and other special charges (Note 6)	`RestructuringSettlementAndImpairmentProvisions`	$31.80M	USD	1 Quarter
Asset impairment, restructuring and other special charges (Note 6)	`RestructuringSettlementAndImpairmentProvisions`	$56.70M	USD	2 Qtrs
Interest expense, net of capitalized interest	`InterestExpense`	$20.70M	USD	1 Quarter
Interest expense, net of capitalized interest	`InterestExpense`	$41.50M	USD	2 Qtrs
Interest expense, net of capitalized interest	`InterestExpense`	-	USD	2 Qtrs
Interest expense, net of capitalized interest	`InterestExpense`	-	USD	1 Quarter
Othernet, expense	`NonoperatingIncomeExpense`	$-6.50M	USD	2 Qtrs
Othernet, expense	`NonoperatingIncomeExpense`	$-3.90M	USD	1 Quarter
Othernet, expense	`NonoperatingIncomeExpense`	$-10.70M	USD	2 Qtrs
Othernet, expense	`NonoperatingIncomeExpense`	$-8.80M	USD	1 Quarter
Costs, expenses and other	`CostsAndExpenses`	$1.47B	USD	2 Qtrs
Costs, expenses and other	`CostsAndExpenses`	$810.20M	USD	1 Quarter
Costs, expenses and other	`CostsAndExpenses`	$1.42B	USD	2 Qtrs
Costs, expenses and other	`CostsAndExpenses`	$731.40M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$37.50M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$50.20M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-40.00M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$95.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$27.60M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$22.80M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$14.30M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$27.60M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$67.40M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-62.80M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$72.70M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$35.90M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$9.90M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$-0.21	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$0.18	USD	2 Qtrs
Basic (usd per share)	`EarningsPerShareBasic`	$0.03	USD	2 Qtrs
Basic (usd per share)	`EarningsPerShareBasic`	$0.10	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$0.10	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$-0.21	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$0.18	USD	2 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$0.03	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	365.70M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	293.30M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	365.70M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	293.30M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	293.30M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	367.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	293.30M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	366.50M	shares	2 Qtrs

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$67.40M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-62.80M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$72.70M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$35.90M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$9.90M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$152.40M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$149.60M	USD	2 Qtrs
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$10.80M	USD	2 Qtrs
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$40.30M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$13.30M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$21.90M	USD	2 Qtrs
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$97.90M	USD	2 Qtrs
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$4.00M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$98.30M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$205.20M	USD	2 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$-22.60M	USD	2 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$700.00K	USD	2 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$58.20M	USD	2 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$183.90M	USD	2 Qtrs
Net purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$56.50M	USD	2 Qtrs
Net purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$51.80M	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$25.70M	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$1.00M	USD	2 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-57.50M	USD	2 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-77.50M	USD	2 Qtrs
Repayments of borrowings (Note 8)	`RepaymentsOfLongTermLinesOfCredit`	$65.00M	USD	2 Qtrs
Repayments of borrowings (Note 8)	`RepaymentsOfLongTermLinesOfCredit`	-	USD	2 Qtrs
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	$191.20M	USD	2 Qtrs
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	-	USD	2 Qtrs
Other net financing transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$-122.80M	USD	2 Qtrs
Other net financing transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$5.00M	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$1.40M	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-900.00K	USD	2 Qtrs
Net Cash Used for Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-249.80M	USD	2 Qtrs
Net Cash Used for Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-123.70M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-11.80M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-5.10M	USD	2 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-280.90M	USD	2 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.40M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$396.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$321.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$396.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$321.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$396.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$321.00M	USD	Point-in-time

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.27B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.78B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.58B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.90B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Net income	`NetIncomeLoss`	$67.40M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$-62.80M	USD	1 Quarter
Net income	`NetIncomeLoss`	$72.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$35.90M	USD	1 Quarter
Net income	`NetIncomeLoss`	$9.90M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-222.90M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$7.40M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-104.30M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$35.60M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$118.60M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-28.20M	USD	1 Quarter
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$-40.30M	USD	1 Quarter
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$-69.20M	USD	1 Quarter
Separation activities	`StockholdersEquitySeparationAdjustments`	$-7.00M	USD	1 Quarter
Separation activities	`StockholdersEquitySeparationAdjustments`	$-18.40M	USD	1 Quarter
Stock compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.40M	USD	1 Quarter
Stock compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.30M	USD	1 Quarter
Other	`StockholdersEquityOther`	$-1.90M	USD	1 Quarter
Balance at end of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.27B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.78B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.58B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.90B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.20B	USD	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$67.40M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-62.80M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$72.70M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$35.90M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$9.90M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-224.90M	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-105.70M	USD	2 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$5.20M	USD	2 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$35.40M	USD	1 Quarter
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-2.20M	USD	2 Qtrs
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.40M	USD	2 Qtrs
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-200.00K	USD	1 Quarter
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-2.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-222.90M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$7.40M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-104.30M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$35.60M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$118.60M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-28.20M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$74.80M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-285.70M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-94.40M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$71.50M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.